Dextrose Electrolytes No 75
"July 14, 2011-- Hospital drug shortages cost hospitals millions each year and may adversely affect patient care, according to a new survey.
''Drug shortages are essentially touching health care systems across the board," says research"...
Dextrose / Electrolytes No. 75
Dextrose Electrolytes No 75 Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
5% Dextrose and Electrolyte No. 75 Injection (multiple electrolytes and dextrose injection, type 3) is a fluid and electrolyte replenishment and caloric supply used as a source of water, electrolytes and calories or as an alkalinizing agent. This medication is available in generic form. Common side effects include skin redness, inflammation, and swelling, or infection at the injection site.
Dosage of 5% Dextrose and Electrolyte No. 75 Injection is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. 5% Dextrose and Electrolyte No. 75 may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, 5% Dextrose and Electrolyte No. 75 Injection should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our 5% Dextrose and Electrolyte No. 75 Injection (multiple electrolytes and dextrose injection, type 3) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Dextrose Electrolytes No 75 FDA Prescribing Information: Side Effects
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Read the entire FDA prescribing information for Dextrose Electrolytes No 75 (5% Dextrose and Electrolyte No. 75 Inj)
Additional Dextrose / Electrolytes No. 75 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Weight Loss Wisdom
Get tips, recipes and inspiration.